Villasís KMÁ, Rendón MME, Escamilla NA

Language: Spanish
References: 22
Page: 164-174
PDF size: 393.29 Kb.

ABSTRACT

Background. Programs for the prevention and management of disease complications and antineoplastic treatment have contributed to improve quality of life and survival of pediatric cancer patients. Despite the above, it remains unclear how to maintain or improve the quality of care. We undertook this study to determine international criteria that establish standards for the optimal management of pediatric patients with acute lymphoblastic leukemia (ALL) or Hodgkin’s lymphoma (HL) by conducting a review of the literature.
Methods. We searched Medline and Google. From the search, we did not identify specific publications for ALL or HL, but the criteria applied for all pediatric cancer patients. Information compiled for each publication is described qualitatively according to three general aspects that determine the quality of medical care: infrastructure, process and outcome.
Results. We selected 21 publications. Nineteen publications describe elements that must be present in all medical units for pediatric patients with cancer. Regarding infrastructure, it is necessary to have multidisciplinary health care professionals specialized in pediatric oncology patients and to have appropriate facilities and supplies. Whereas the process of care includes identifying and providing appropriate treatment for complications at any time, availability of treatment protocols proven to be effective and continuous training for staff, as well as a program for evaluation of the quality of care. Two publications reported that after implementing most of the elements described, there is decrease in mortality of children with cancer in developing countries.
Conclusions. Although the number of elements for the provision of optimal care for children with cancer is high, their implementation contributes to the improvement of quality of care and survival.

REFERENCES

1. Simone JV. History of the treatment of childhood ALL: a paradigm for cancer cure. Best Pract Res Clin Haematol 2006;19:353-359.

2. American Academy of Pediatrics. Guidelines for pediatric cancer centers. Pediatrics 2004;113:1833-1835.

3. Children’s Oncology Group. Requirements Institutional Membership. Disponible en: http://www.childrensoncologygroup.org/downloads/3.1.2ReqInstMmbrshp.pdf

4. Research Triangle Institute. U.S. News & World Report. Best Children’s Hospitals 2010 Methodology. Disponible en: http://static.usnews.com/documents/health/best-childrensmethodology.pdf.

5. von Stackelberg A, Karatchunsky A, Kudrjashova J, Miakova N, Belikova L, Rumiantzev A, et al. Toxicity, supportive care and costs of two chemotherapy protocols for treatment of childhood ALL in Russia: BFM 90m and MB 91. Eur J Cancer 1999;35:1349-1355.

6. Arya LS. Acute lymphoblastic leukemia: current treatment concepts. Indian Pediatr 2000;37:397-406.

7. Scopinaro MJ, Casak SJ. Paediatric oncology in Argentina: medical and ethical issues. Lancet Oncol 2002;3:111-117.

8. Yaris N, Mandiracioglu A, Büyükpamukcu M. Childhood cancer in developing countries. Pediatr Hematol Oncol 2004;21:237-253.

9. Valsecchi MG, Tognoni G, Bonilla M, Moreno N, Baez F, Pacheco C, et al. Clinical epidemiology of childhood cancer in Central America and Caribbean countries. Ann Oncol 2004;15:680-685. doi:10.1093/annonc/mdh148.

10. Pui CH, Schrappe M, Masera G, Nachman J, Gadner H, Eden OB, et al. Ponte di Legno Working Group: statement on the right of children with leukemia to have full access to essential treatment and report on the Sixth International Childhood Acute Lymphoblastic Leukemia Workshop. Leukemia 2004;18:1043-1053.

11. Ribeiro RC, Pui CH. Saving the children—improving childhood cancer treatment in developing countries. N Engl J Med 2005;352:2158-2160.

12. Veerman AJ, Sutaryo, Sumadiono. Twinning: a rewarding scenario for development of oncology services in transitional countries. Pediatr Blood Cancer 2005;45:103-106.

13. Barr RD, Sala A, Wiernikowski J, Masera G, Mato G, Antillon F, et al. A formulary for pediatric oncology in developing countries. Pediatr Blood Cancer 2005;44:433-435.

14. Rosenman MB, Vik T, Hui SL, Breitfeld PP. Hospital resource utilization in childhood cancer. J Pediatr Hematol Oncol 2005;27:295-300.

15. Gao YJ, Lu FJ, Wang HS. Treating childhood acute lymphoblastic leukemia in a developing country 1998-2003: the experience of a single children's hospital in China. J Pediatr Hematol Oncol 2006;28:798-802.

16. Harif M. Pediatric hematology/oncology in Morocco. SIOP Education Book 2006. Disponible en: https://www.cure4kids.org/private/courses_documents/m_191/Harif.pdf

17. Lie SO. Promoting paediatric oncology in developing countries. SIOP Education Book 2007. Disponible en: https://www.cure4kids.org/private/courses_documents/m_259/Promoting%20Paediatric%20Oncology%20in%20Developing%20Countries.pdf

18. Howard SC, Marinoni M, Castillo L, Bonilla M, Tognoni G, Luna-Fineman S, et al. Improving outcomes for children with cancer in low-income countries in Latin America: a report on the recent meetings of the Monza International School of Pediatric Hematology/Oncology (MISPHO)-Part I. Pediatr Blood Cancer 2007;48:364-369.

19. Craft AW. Paediatric oncology: the past and the future. SIOP Education Book 2008. Disponible en: https://www.cure4kids.org/private/courses_documents/m_366/Paediatric_Oncology_Past_Future.pdf

20. Marwaha RK, Kulkarni KP, Bansal D, Trehan A. Pattern of mortality in childhood acute lymphoblastic leukemia: experience from a single center in northern India. J Pediatr Hematol Oncol 2010;32:366-369.

21. Bonilla M, Moreno N, Marina N, de Reyes G, Shurtleff SA, Downing JR, et al. Acute lymphoblastic leukemia in a developing country: preliminary results of a nonrandomized clinical trial in El Salvador. J Pediatr Hematol Oncol 2000;22:495-501.

22. Howard SC, Pedrosa M, Lins M, Pedrosa A, Pui CH, Ribeiro RC, et al. Establishment of a pediatric oncology program and outcomes of childhood acute lymphoblastic leukemia in a resource-poor area. JAMA 2004;291:2471-2475.